sEH activity in diabetes is thought to be responsible for pericyte loss and endothelial barrier dysfunction by promoting the production of pro-inflammatory diol 19,20-DHDP, the hydrolysis product of 19,20-EDP59. This evidence concerns the gene EPHX2 and diabetes mellitus.